Stockscreener 앱 받기
15.56
2.77%
0.42
시간 외 거래:
15.66
0.10
+0.64%
Fulgent Genetics Inc 주식(FLGT)의 최신 뉴스
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - GlobeNewswire Inc.
Trading the Move, Not the Narrative: (FLGT) Edition - Stock Traders Daily
Published on: 2026-03-19 03:58:12 - baoquankhu1.vn
Fulgent Genetics Completes $56.9M Acquisition of Bako Diagnostics and StrataDx to Expand Precision Medicine Services - Minichart
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx - BioSpace
Fulgent Genetics completes $56.9M pathology lab acquisitions By Investing.com - Investing.com India
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - Business Wire
Fulgent Genetics Acquires Bako Diagnostics Assets, StrataDx for $56.9 Million - marketscreener.com
Fulgent Genetics completes $56.9M pathology lab acquisitions - Investing.com
Fulgent Genetics Expands Dermatology Footprint With Key Acquisitions - TipRanks
Fulgent Genetics (NASDAQ: FLGT) buys Bako Diagnostics and StrataDx - Stock Titan
Fulgent Genetics (NASDAQ:FLGT) Stock Price Crosses Below 50-Day Moving AverageHere's Why - MarketBeat
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - The Globe and Mail
Fulgent Genetics (FLGT) Stock Analysis Report | Financials & Insights - Benzinga España
Fulgent Genetics seeks new collaborations at Copenhagen ADPD2026 event - Traders Union
Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics - GlobeNewswire
Fulgent Genetics: A Major Market Misconception (NASDAQ:FLGT) - Seeking Alpha
Fulgent Genetics (NASDAQ: FLGT) CEO pays $10.7M to cancel share forward - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - FinancialContent
Fulgent Genetics (FLGT) Earnings Transcript - AOL.com
Aug Sectors: Should I hold or sell Fulgent Genetics Inc now2026 Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
Fulgent Genetics Hits New 52-Week Low at $14.01 Amid Declining Performance - Markets Mojo
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Technical Analysis: Is Fulgent Genetics Inc a top pick in the sectorQuarterly Earnings Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Fulgent Genetics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:FLGT) 2026-03-05 - Seeking Alpha
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of "Hold" by Brokerages - MarketBeat
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - FinancialContent
FLGT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fulgent Genetics (FLGT) CSO has shares withheld to cover RSU taxes - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) CEO has shares withheld for taxes - Stock Titan
Fulgent Genetics (FLGT) Is Down 33.4% After 2025 Results And Oncology-Focused ExpansionWhat's Changed - Yahoo Finance
Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach - GlobeNewswire
UBS Adjusts Fulgent Genetics Price Target to $22 From $35, Maintains Buy Rating - marketscreener.com
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results - marketscreener.com
Assessing Fulgent Genetics (FLGT) Valuation After Earnings Outperformance And AI Oncology Pipeline Progress - simplywall.st
A Look At Fulgent Genetics (FLGT) Valuation After 2025 Results And 2026 Revenue Guidance - Yahoo Finance
Fulgent Genetics (NASDAQ:FLGT) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Fulgent Q4 2025 slides: EPS beats, but customer loss drives stock plunge - Investing.com Australia
Fulgent Genetics (FLGT) Loss Widening In Q4 2025 Tests Bullish Growth Narratives - simplywall.st
Fulgent Genetics (FLGT) Reports Strong Q4 Revenue Growth - GuruFocus
Fulgent Genetics (NASDAQ:FLGT) Issues FY 2026 Earnings Guidance - MarketBeat
Fulgent Genetics Inc (FLGT) Q4 2025 Earnings Call Highlights: Na - GuruFocus
Fulgent Genetics Q4 Earnings Call Highlights - MarketBeat
Fulgent Genetics (FLGT) Reports Strong Q4 Earnings Despite Reven - GuruFocus
Earnings call transcript: Fulgent Genetics Q4 2025 beats EPS estimates, stock tumbles - Investing.com
Fulgent Genetics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fulgent Genetics earnings beat by $0.22, revenue fell short of estimates - Investing.com Canada
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates - Yahoo Finance
Fulgent Genetics Posts 2025 Results and 2026 Outlook - TipRanks
Fulgent Genetics (FLGT) Reports Q4 Revenue Below Expectations - GuruFocus
FLGT Projects FY26 Revenue and Financial Outlook - GuruFocus
Fulgent Genetics Q4 Non-GAAP Net Income, Revenue Rise; 2026 Guidance Set -- Shares Down Pre-Bell - marketscreener.com
0.55%
2.50%
자본화:
|
볼륨(24시간):